The awards come as Haleon’s stock trades near its 52-week high of $10.80, having delivered an impressive 25.4% return over the past year. These awards are tied to specific performance conditions ...

AMSTERDAM: in-cosmetics Global, the leading global event for personal care, today announced the winners of the 2025 Awards, ...

Pfizer reportedly raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon, ending a years-long separation with the company, per Bloomberg and Yahoo ...

(Reuters) -Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer healthcare firm at 385 pence per share ...

Pfizer (NYSE:PFE) has generated £2.5B ($3.24B) after selling its entire stake in Haleon (NYSE:HLN), the consumer healthcare company it established with the British pharmaceutical giant GSK (GSK ...

Pfizer intends to sell its remaining residual shareholding in Haleon through a share placing, Citigroup said Tuesday. According to the release, the U.S. drugmaker will sell 662 million shares to ...

(Reuters) -Pfizer will sell its remaining stake in British consumer healthcare group Haleon, the companies said on Tuesday. Pfizer will sell about 662 million ordinary shares, or 7.3%, of Haleon ...

Pfizer sells entire Haleon stake for $3.24 billion Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer ...

Haleon plc (LSE/NYSE:LON:HLN), a global leader in consumer health with a market capitalization of $46.22 billion and a "GOOD" financial health rating according to InvestingPro, disclosed the granting ...